BOSTON (AP) — The San Diego company that makes the powerful new prescription painkiller Zohydro is selling off its migraine therapy business to focus on developing abuse-resistant forms of Zohydro.
Zogenix Chief Executive Officer Roger Hawley said the sale will help the company focus on the launch of Zohydro ER while providing capital "to continue the development of two abuse-deterrent formulations" of the opioid.
The company announced in November it would pursue an abuse-deterrent form of the drug.
Health officials around the country worry addicts will crush Zohydro capsules and then snort or inject the drug to get high.
Citing such worries, Massachusetts Gov. Deval Patrick tried to ban the drug, but a federal court blocked the state from enforcing the ban. Patrick has since announced new restrictions on the drug.
Have We Not More Faith Than This? | RedState
WaPo: Yeah, Hillary sent six e-mails with classified material — so far - Hot Air
Daniel J. Mitchell - Does Donald Trump Think Washington Politicians Should Have More of Our Money to Help America Become Greece?
FATAL SELFIE: Teen Killed Taking Instagram Photo With Gun To His Head - Bearing Arms - Negligent Discharge, Texas
Elon Musk’s Crony Capitalism under Scrutiny | Human Events
Katie Pavlich - WATCH: Sheriff David Clarke Takes on Cop Killer Advocate on CNN
'Why hasn't Hillary been charged?' Andrea Tantaros has questions about Clinton email 'coverup'